Stille AB

Stille AB maintains a conservative capital structure with a debt-to-equity ratio of 0.15, indicating a low reliance on debt financing. The company's liquidity position is characterized by a current ratio of 3.52, suggesting strong short-term liquidity. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Stille AB's return on equity (ROE) of 7.86% and return on assets (ROA) of 5.28% are below the industry median for medical equipment and supplies companies, indicating that the company is underperforming relative to its peers in generating returns from equity and assets. The operating margin, calculated as operating income of 73.24 million SEK on revenue of 567.63 million SEK, is 12.91%, which is in line with the industry average. Geographically, Stille AB's revenue is concentrated in its domestic market, with no disclosed international segments. This concentration increases exposure to local economic and regulatory risks. The company's revenue concentration in a single geographic region is a notable risk factor, as it limits diversification and exposes the company to regional economic downturns. Looking ahead, Stille AB is projected to experience modest revenue growth, with a free cash flow of 68.47 million SEK and capital expenditures of -20.59 million SEK. The company's operating cash flow of 36.06 million SEK supports its liquidity position, but the negative capital expenditures suggest a potential reduction in investment in long-term assets. The company's growth trajectory is expected to remain stable, with no significant changes in revenue or operating performance anticipated in the near term. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's liquidity risk is primarily due to its negative net cash position after accounting for total debt, which could limit its ability to meet short-term obligations. The dilution risk is low, as the company has not issued additional shares recently, and there is no indication of a dilutive event in the near future. The company's capital structure remains stable, with no significant changes in shares outstanding or dilution potential. Recent events and disclosures indicate that Stille AB has not issued any new shares or engaged in significant capital-raising activities. The company's financial statements show a consistent pattern of revenue and profit generation, with no material changes in its business operations or strategic direction. Analysts have provided a mean price target of 279.00 SEK, with a single "buy" recommendation and no "strong buy" or "hold" ratings, suggesting a cautious outlook from the investment community.